Farmorubicin RTU 50mg Injection

Farmorubicin RTU 50mg injection contains epirubicin hydrochloride, an antineoplastic drug belonging to the anthracycline class. It is used as adjuvant therapy in combination with other medications for breast cancer in patients who have undergone surgical removal of the tumour. This medicine is also indicated in cancers of the breast, ovaries, stomach, bowel, and lung. It is additionally used in cancers of the blood-forming tissues, including malignant lymphomas, leukaemias, and multiple myeloma.

Do not use Farmorubicin RTU 50mg injection if you are allergic to epirubicin or any other ingredients in this medicine, if you are pregnant or breastfeeding, or if you have severe liver and bladder problems. Before starting treatment, inform your doctor if you have kidney or liver problems, have had recent vaccination, or if you have acute toxicities such as acute inflammation of the mouth, low white blood cell count, low platelet count, or any infections. This medicine may increase your risk of blood clots. Farmorubicin injection may cause infertility in men and women; inform your doctor if you are planning pregnancy. If you are sexually active, use effective birth control to prevent pregnancy. Your doctor will perform regular laboratory tests to monitor the effects of this medicine.

Common side effects of Farmorubicin RTU 50mg injection include decreased WBC, platelets, irregular menstruation, weakness, nausea or vomiting, diarrhoea, eye infection, skin rashes, or itchiness. Farmorubicin RTU 50mg injection price varies based on the distributor and location.

Breast cancer Stomach and bowel cancer Ovarian cancer Lung cancer

Farmorubicin RTU 50mg injection inhibits DNA, RNA, and protein synthesis by exerting cytotoxic activity. It works by slowing or stopping the growth of the cancer cells. This medicine helps to selectively kill cancer cells rather than normal, healthy cells.

Farmorubicin 50mg side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common Hair loss Flushing Rash, itching Diarrhea Nausea and vomiting Anemia Decreased WBC and platelets Eye infection Irregular menstruation Serious Congestive heart failure Increased blood urea levels Severe hypersensitivity reaction Lung problems

Inform your physician if you are receiving radiation therapy with this medicine. This medicine may cause birth defects if either partner uses it during conception or pregnancy. Male patients with female partners of reproductive potential should use effective birth control during the treatment and for 3 months after the last dose. Do not breastfeed during the treatment and for 7 days after the last dose. The medicine may turn your urine red for 1 or 2 days after your treatment.